Premium
Lipocine Inc (LPCN)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other produ... Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other products in the pipeline such as LPCN 1144 LPCN 1148 and LPCN 1107. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.06 | 2.01342281879 | 2.98 | 3.6215 | 2.9101 | 15380 | 3.2567072 | CS |
| 4 | -0.43 | -12.3919308357 | 3.47 | 3.7866 | 2.9101 | 13738 | 3.3514941 | CS |
| 12 | -1.66 | -35.3191489362 | 4.7 | 5.5 | 2.9101 | 29637 | 4.35288092 | CS |
| 26 | -0.92 | -23.2323232323 | 3.96 | 6.1683 | 2.9101 | 30309 | 4.73112013 | CS |
| 52 | -0.6 | -16.4835164835 | 3.64 | 11.79 | 2.9101 | 44644 | 5.76885059 | CS |
| 156 | -22.63 | -88.1573821582 | 25.67 | 32.13 | 2.3101 | 155562 | 13.04639929 | CS |
| 260 | -5.63 | -64.9365628604 | 8.67 | 41.14 | 2.3101 | 871745 | 24.62073194 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
